A Resisted Pill to Prevent HIV

The New York Times reports that many health experts hoped that the medication Truvada, a combination of two antiviral drugs that has been used to treat H.I.V. since 2004, would be exuberantly embraced by H.I.V.-negative gay men. Instead, Truvada has been slow to catch on as an H.I.V. preventive in the 18 months since the strategy’s approval by the FDA.

Read the full story from The New York Times

Lavender Magazine

5100 Eden Ave, Suite 107
Edina, MN 55436
612.436.4660

Lav Link Newsletter

©2021 Lavender Media, Inc.